XML 149 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8
Other Investments
12 Months Ended
Dec. 31, 2013
Regulated Entity, Other Assets, Noncurrent [Abstract]  
Other Investments
Other Investments
Nuclear Decommissioning Trusts
Future decommissioning costs of removal of SCE's nuclear assets are expected to be funded from independent decommissioning trusts, which currently receive contributions of approximately $23 million per year through SCE customer rates. Contributions to the decommissioning trusts are reviewed every three years by the CPUC.
The following table sets forth amortized cost and fair value of the trust investments:
 
Longest
Maturity Date
 
Amortized Cost
 
Fair Value
 
 
December 31,
(in millions)
 
 
2013
 
2012
 
2013
 
2012
Stocks
 
$
656

 
$
978

 
$
2,208

 
$
2,271

Municipal bonds
2051
 
675

 
518

 
756

 
644

U.S. government and agency securities
2044
 
902

 
547

 
947

 
603

Corporate bonds
2054
 
208

 
324

 
241

 
410

Short-term investments and receivables/payables
One-year
 
329

 
116

 
342

 
120

Total
 
 
$
2,770

 
$
2,483

 
$
4,494

 
$
4,048


Trust fund earnings (based on specific identification) increase the trust fund balance and the ARO regulatory liability. Proceeds from sales of securities (which are reinvested) were $5.6 billion, $2.1 billion and $2.8 billion for the years ended December 31, 2013, 2012 and 2011, respectively. Unrealized holding gains, net of losses, were $1.7 billion and $1.6 billion at December 31, 2013 and 2012, respectively.
The following table sets forth a summary of changes in the fair value of the trusts:
 
Years ended December 31,
(in millions)
2013
 
2012
 
2011
Balance at beginning of period
$
4,048

 
$
3,592

 
$
3,480

Gross realized gains
300

 
73

 
108

Gross realized losses
(32
)
 
(5
)
 
(17
)
Unrealized gains (losses), net
160

 
276

 
(7
)
Other-than-temporary impairments
(47
)
 
(36
)
 
(47
)
Interest, dividends, contributions and other
65

 
148

 
75

Balance at end of period
$
4,494

 
$
4,048

 
$
3,592


Due to regulatory mechanisms, earnings and realized gains and losses (including other-than-temporary impairments) have no impact on operating revenue or earnings.